DK1773810T3 - Hidtil ukendte 4-benzylidenpiperidinderivater - Google Patents

Hidtil ukendte 4-benzylidenpiperidinderivater

Info

Publication number: DK1773810T3
Authority: DK; Denmark
Prior art keywords: new; piperidine derivatives; benzylidene piperidine; benzylidene; derivatives
Prior art date: 2004-07-29

Application number

DK05763197T

Other languages

Danish (da)

English (en)

Inventor

Istvan Borza

Sandor Kolok

Csilla Horvath

Sandor Farkas

Istvan Gyertyan

Jozsef Nagy

Kornel Galgeczy

Katalin Saghy

Original Assignee

Richter Gedeon Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-29

Filing date

2005-07-21

Publication date

2008-06-23

2005-07-21 Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet

2008-06-23 Application granted granted Critical

2008-06-23 Publication of DK1773810T3 publication Critical patent/DK1773810T3/da

Links

QMQNIKYRPSFQKB-UHFFFAOYSA-N 4-benzylidenepiperidine Chemical class C1CNCCC1=CC1=CC=CC=C1 QMQNIKYRPSFQKB-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Psychology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK05763197T 2004-07-29 2005-07-21 Hidtil ukendte 4-benzylidenpiperidinderivater DK1773810T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU0401522A HUP0401522A2 (en)	2004-07-29	2004-07-29	New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
PCT/HU2005/000077 WO2006010964A1 (en)	2004-07-29	2005-07-21	New 4-benzylidene-piperidin derivatives

Publications (1)

Publication Number	Publication Date
DK1773810T3 true DK1773810T3 (da)	2008-06-23

Family

ID=89985407

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05763197T DK1773810T3 (da)	2004-07-29	2005-07-21	Hidtil ukendte 4-benzylidenpiperidinderivater

Country Status (31)

Country	Link
US (1)	US8008326B2 (pt)
EP (1)	EP1773810B1 (pt)
JP (1)	JP4814880B2 (pt)
KR (1)	KR20070058428A (pt)
CN (1)	CN1989128A (pt)
AP (1)	AP2074A (pt)
AT (1)	ATE387440T1 (pt)
AU (1)	AU2005266159B2 (pt)
BR (1)	BRPI0513902A (pt)
CA (1)	CA2574148A1 (pt)
CY (1)	CY1107368T1 (pt)
DE (1)	DE602005005064T2 (pt)
DK (1)	DK1773810T3 (pt)
EA (1)	EA011241B1 (pt)
ES (1)	ES2302214T3 (pt)
GE (1)	GEP20084492B (pt)
HR (1)	HRP20080127T3 (pt)
HU (1)	HUP0401522A2 (pt)
IL (1)	IL179484A0 (pt)
MA (1)	MA28816B1 (pt)
MX (1)	MX2007001055A (pt)
NO (1)	NO20071108L (pt)
NZ (1)	NZ552137A (pt)
PL (1)	PL1773810T3 (pt)
PT (1)	PT1773810E (pt)
RS (1)	RS50573B (pt)
SI (1)	SI1773810T1 (pt)
TN (1)	TNSN07018A1 (pt)
UA (1)	UA87862C2 (pt)
WO (1)	WO2006010964A1 (pt)
ZA (1)	ZA200700320B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2520567A3 (en)	2006-02-23	2012-12-12	Shionogi & Co., Ltd.	Nitrogen-containing heterocycle derivatives substituted with cyclic group
CN101426381A (zh) *	2006-04-21	2009-05-06	西诺米克斯公司	含有高效鲜味调料的可食用组合物及其制备方法
ES2347192T3 (es) *	2006-06-08	2010-10-26	Bristol-Myers Squibb Company	Derivados de alqueno piperidina como agentes antivirales.
CA2730253A1 (en) *	2008-07-08	2010-01-14	Alphonso Higuera	Novel crystalline form of 2-[4-(4-fluoro-benzyl)-piperidine-1-yl]-2-oxo-n-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-acetamide
CA2788656A1 (en)	2010-02-16	2011-08-25	Pfizer Inc.	(r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
WO2012033069A1 (ja)	2010-09-07	2012-03-15	大鵬薬品工業株式会社	プロスタグランジンd合成酵素を阻害するピペリジン化合物
US20120322824A1 (en) *	2011-01-04	2012-12-20	Surratt Christopher K	Cocaine Antagonist/Antidepressant Pharmaceutical Preparations
KR20140146217A (ko)	2012-04-20	2014-12-24	유씨비 파마, 에스.에이.	파킨슨병을 치료하는 방법
EP3868752A1 (en)	2014-08-28	2021-08-25	Asceneuron SA	Glycosidase inhibitors
EP3389658B1 (en) *	2015-12-18	2020-11-25	Merck Sharp & Dohme Corp.	Glycosidase inhibitors and uses thereof
US11261183B2 (en)	2016-02-25	2022-03-01	Asceneuron Sa	Sulfoximine glycosidase inhibitors
CN108884078A (zh)	2016-02-25	2018-11-23	阿森纽荣股份公司	糖苷酶抑制剂
SG11201807012QA (en)	2016-02-25	2018-09-27	Asceneuron S A	Acid addition salts of piperazine derivatives
AU2017222958B2 (en)	2016-02-25	2019-07-18	Asceneuron S. A.	Glycosidase inhibitors
US9486444B1 (en)	2016-03-21	2016-11-08	King Saud University	Anti-cancer compound
WO2019037860A1 (en)	2017-08-24	2019-02-28	Asceneuron S.A.	LINEAR INHIBITORS OF GLYCOSIDASE
IL280841B2 (en)	2018-08-22	2024-12-01	Asceneuron S A	Succinate and fumarate acid addition salts of piperazine derivatives useful as glycosidase inhibitors
WO2020039027A1 (en)	2018-08-22	2020-02-27	Asceneuron S. A.	Pyrrolidine glycosidase inhibitors
WO2020039028A1 (en)	2018-08-22	2020-02-27	Asceneuron S. A.	Tetrahydro-benzoazepine glycosidase inhibitors
WO2020039029A1 (en)	2018-08-22	2020-02-27	Asceneuron S. A.	Spiro compounds as glycosidase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA9610738B (en) *	1995-12-22	1997-06-24	Warner Lambert Co	Subtype selective nmda receptor ligands and the use thereof
TW498067B (en) *	1996-07-19	2002-08-11	Hoffmann La Roche	4-hydroxy-piperidine derivatives
CA2220649C (en)	1996-12-03	2007-02-13	F. Hoffmann-La Roche Ag	4-hydroxy-piperidine derivatives
CA2453383C (en) *	2001-07-24	2010-04-06	Richter Gedeon Vegyeszeti Gyar Rt	Piperidine derivatives as nmda receptor antagonists

2004
- 2004-07-29 HU HU0401522A patent/HUP0401522A2/hu unknown
2005
- 2005-07-21 US US11/658,789 patent/US8008326B2/en not_active Expired - Fee Related
- 2005-07-21 HR HR20080127T patent/HRP20080127T3/xx unknown
- 2005-07-21 CN CNA2005800243746A patent/CN1989128A/zh active Pending
- 2005-07-21 CA CA002574148A patent/CA2574148A1/en not_active Abandoned
- 2005-07-21 WO PCT/HU2005/000077 patent/WO2006010964A1/en not_active Ceased
- 2005-07-21 AU AU2005266159A patent/AU2005266159B2/en not_active Ceased
- 2005-07-21 BR BRPI0513902-3A patent/BRPI0513902A/pt not_active IP Right Cessation
- 2005-07-21 RS RSP-2008/0123A patent/RS50573B/sr unknown
- 2005-07-21 GE GEAP20059892A patent/GEP20084492B/en unknown
- 2005-07-21 PL PL05763197T patent/PL1773810T3/pl unknown
- 2005-07-21 DK DK05763197T patent/DK1773810T3/da active
- 2005-07-21 KR KR1020077000262A patent/KR20070058428A/ko not_active Ceased
- 2005-07-21 EA EA200700367A patent/EA011241B1/ru not_active IP Right Cessation
- 2005-07-21 JP JP2007523160A patent/JP4814880B2/ja not_active Expired - Fee Related
- 2005-07-21 MX MX2007001055A patent/MX2007001055A/es active IP Right Grant
- 2005-07-21 EP EP05763197A patent/EP1773810B1/en not_active Expired - Lifetime
- 2005-07-21 UA UAA200702171A patent/UA87862C2/ru unknown
- 2005-07-21 SI SI200530213T patent/SI1773810T1/sl unknown
- 2005-07-21 DE DE602005005064T patent/DE602005005064T2/de not_active Expired - Lifetime
- 2005-07-21 AT AT05763197T patent/ATE387440T1/de active
- 2005-07-21 NZ NZ552137A patent/NZ552137A/xx not_active IP Right Cessation
- 2005-07-21 PT PT05763197T patent/PT1773810E/pt unknown
- 2005-07-21 ES ES05763197T patent/ES2302214T3/es not_active Expired - Lifetime
- 2005-07-21 AP AP2006003839A patent/AP2074A/en active
2006
- 2006-11-22 IL IL179484A patent/IL179484A0/en unknown
2007
- 2007-01-11 ZA ZA200700320A patent/ZA200700320B/en unknown
- 2007-01-17 TN TNP2007000018A patent/TNSN07018A1/en unknown
- 2007-02-22 MA MA29703A patent/MA28816B1/fr unknown
- 2007-02-27 NO NO20071108A patent/NO20071108L/no not_active Application Discontinuation
2008
- 2008-03-27 CY CY20081100349T patent/CY1107368T1/el unknown

Also Published As

Publication number	Publication date
HUP0401522A2 (en)	2006-04-28
IL179484A0 (en)	2007-05-15
EP1773810A1 (en)	2007-04-18
AU2005266159A1 (en)	2006-02-02
PL1773810T3 (pl)	2008-07-31
AU2005266159B2 (en)	2011-09-29
AP2074A (en)	2009-12-14
HRP20080127T3 (hr)	2008-04-30
KR20070058428A (ko)	2007-06-08
US20080312222A1 (en)	2008-12-18
ES2302214T3 (es)	2008-07-01
EA200700367A1 (ru)	2007-06-29
MA28816B1 (fr)	2007-08-01
WO2006010964A1 (en)	2006-02-02
EP1773810B1 (en)	2008-02-27
HK1105966A1 (en)	2008-02-29
HU0401522D0 (en)	2004-09-28
JP4814880B2 (ja)	2011-11-16
DE602005005064D1 (de)	2008-04-10
RS50573B (sr)	2010-05-07
CN1989128A (zh)	2007-06-27
UA87862C2 (en)	2009-08-25
EA011241B1 (ru)	2009-02-27
US8008326B2 (en)	2011-08-30
AP2006003839A0 (en)	2006-12-31
CA2574148A1 (en)	2006-02-02
TNSN07018A1 (en)	2008-06-02
ATE387440T1 (de)	2008-03-15
MX2007001055A (es)	2007-04-16
GEP20084492B (en)	2008-09-25
NO20071108L (no)	2007-02-27
DE602005005064T2 (de)	2009-02-26
NZ552137A (en)	2009-08-28
JP2008508247A (ja)	2008-03-21
ZA200700320B (en)	2008-05-28
PT1773810E (pt)	2008-04-09
SI1773810T1 (sl)	2008-06-30
BRPI0513902A (pt)	2008-05-20
CY1107368T1 (el)	2012-12-19

Publication	Publication Date	Title
IS8578A (is)	2006-12-08	3- karbamoýl - 2- pýridón afleiður
DK1515969T3 (da)	2010-12-13	Spiroindolinpiperidinderivater
EP1741703A4 (en)	2009-11-25	pyridone
DK1725553T3 (da)	2008-08-18	Tetrahydropyridoindolderivater
ATE540935T1 (de)	2012-01-15	Chinazolinderivate
DK1594840T3 (da)	2007-02-05	Piperidin-benzensulfonamid-derivater
DK1761541T3 (da)	2008-04-28	Pyrrazolo-pyrimidin-derivater
ATE553079T1 (de)	2012-04-15	Heteroarylphenylharnstoffderivat
ATE352550T1 (de)	2007-02-15	Chinazolinderivate
ATE420066T1 (de)	2009-01-15	Amidoacetonitrilderivate
DE502005010218D1 (de)	2010-10-21	Spiralbohrer
DK1773810T3 (da)	2008-06-23	Hidtil ukendte 4-benzylidenpiperidinderivater
ATE395345T1 (de)	2008-05-15	Imidazol-4-yl-ethynyl-pyridin-derivate
IS8180A (is)	2005-12-14	Nýjar besímídasólafleiður
ATE308543T1 (de)	2005-11-15	Piperidinderivate
ATE417830T1 (de)	2009-01-15	Sulfonylbenzimidazolderivate
MA28801B1 (fr)	2007-08-01	Composition antihistaminique
NL2000937A1 (nl)	2008-01-11	Piperidinederivaten.
ATE354365T1 (de)	2007-03-15	N-thiazol-2-yl-benzamid-derivate
ATE430142T1 (de)	2009-05-15	Phenylpiperazin-methanon-derivate
SE0403024L (sv)	2006-06-15	Borrningsverktyg
DK1706373T3 (da)	2010-01-18	Amidoacetonitrilderivater
ATE404542T1 (de)	2008-08-15	4-phenylpyrimidin-2-carbonitrilderivate
IS8045A (is)	2005-09-26	Púrín-6-ón-afleiður
ATE365731T1 (de)	2007-07-15	4-amino-5-cyanopyrimidinderivate